Internal consistency and reliability of the Swiss-French translation of the venous leg ulcer self efficacy tool (VeLUSET) by Probst, Sebastian et al.
1Probst S, et al. BMJ Open 2019;9:e031529. doi:10.1136/bmjopen-2019-031529
Open access 
Internal consistency and reliability of 
the Swiss- French translation of the 
venous leg ulcer self efficacy 
tool (VeLUSET)
Sebastian Probst   ,1 Mathieu Turcotte,2 Monika Buehrer Skinner3
To cite: Probst S, Turcotte M, 
Buehrer Skinner M.  Internal 
consistency and reliability of the 
Swiss- French translation of the 
venous leg ulcer self efficacy 
tool (VeLUSET). BMJ Open 
2019;9:e031529. doi:10.1136/
bmjopen-2019-031529
 ► Prepublication history for 
this paper is available online. 
To view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2019- 
031529).
Received 09 May 2019
Revised 07 November 2019
Accepted 11 November 2019
1Geneva School of Health 
Sciences, HES- SO Genève, 
Genève, Switzerland
2La Source, HES- SO, Lausanne, 
Switzerland
3Epidemiology, Biostatistics and 
Prevention Institute, University of 
Zurich, Zurich, Switzerland
Correspondence to
Professor Sebastian Probst;  
 sebastian. probst@ hesge. ch
Original research
© Author(s) (or their 
employer(s)) 2019. Re- use 
permitted under CC BY- NC. No 
commercial re- use. See rights 
and permissions. Published by 
BMJ.
Strengths and limitations of this study
 ► The study had a high participation rate. 
 ►  The study has a high level of data- completeness. 
 ►  Reliability was examined using Bland- Altman, 
Pearson’s correlation coefficient as well as Lin’s 
concordance correlation coefficient with 95% CIs. 
 ►  Generalisation is possibly limited of the French- 
speaking population of Switzerland.  
AbStrACt
Objective This study was conducted to assess the 
psychometric properties of the translated and adapted 
Venous Leg Ulcer Self Efficacy Tool (VeLUSET) in the new 
cultural context.
Design Validation study
Setting Three outpatient clinics in Western Switzerland.
Participants 32 consecutive persons with venous leg 
ulcers (VLU).
Main outcome measures To determine the internal 
consistency and reliability of the VeLUSET for use in a 
Swiss- French speaking venous leg ulcer population.
results Overall, the Cronbach alpha for the VeLUSET- FR 
was 0.96 (95% CI 0.93 to 0.98) on test and retest. Lin’s 
concordance correlation coefficient of test and retest 
scores was 0.93 (95% CI 0.86 to 0.96).
Conclusion The results indicate that the VeLUSET- FR is 
a valid and reliable instrument for measuring self- efficacy 
among Swiss- French persons affected by a venous leg 
ulcer. Our findings show that the psychometric properties 
are similar to those of the original tool. Therefore, we 
suggest that the VeLUSET- FR can be effectively used for 
measuring self- efficacy in Swiss- French persons with VLU.
IntrODuCtIOn
Venous leg ulcers (VLU) are caused by 
chronic venous insufficiency. The prevalence 
can reach up to 3% in the general population 
in industrialised countries.1 In 60% of cases 
these wounds heal within three to 6 months, 
another 33% heal within 1 year. In 7% of 
cases, wound closure never occurs.2 Up to 
70% of persons with leg ulcers suffer a recur-
rence within 3 months after wound closure.3–5 
Hence, VLUs are a health problem that often 
accompanies a person for life.6
Consequently, these wounds are a burden 
not only on the affected persons as they, 
cause pain and suffering, they also require 
expensive treatment which is a burden on 
their personal budget, their social environ-
ment and on society as a whole. The esti-
mated annual treatment- costs for 2.2 million 
persons with VLU in the United Kingdom are 
estimated to be in the vicinity of £6 billion.7
Current therapeutic approaches for VLUs 
are multifaceted and focus on promoting 
wound healing as well as the prevention of 
ulcer recurrences.8 This is achieved through 
the wearing of compression hosiery, leg and 
ankle exercises, elevation and a healthy and 
balanced diet.8 9 However, adherence to the 
therapeutic recommendations is poor.10 11
As an explanation for this low level of ther-
apeutic adherence the literature cites a lack 
of knowledge.11–13 As a lack of knowledge is 
associated with a low level of self- care and 
self- efficacy (the confidence in one’s ability 
to perform a task successfully),14–16 a prom-
ising strategy to prevent VLU recurrences 
could be the strengthening/improvement of 
self- efficacy and self- care. Additionally a high 
level of self- efficacy was identified as a deter-
minant for decreased hospital re- admission 
rates and increased quality of life.17
Currently, only one self- efficacy instrument 
has been developed to measure the self- 
efficacy of persons with VLU in their self- care 
activities, the VeLUSET.16 17 It measures the 
self- care and—indirectly—the knowledge 
level of persons with leg ulcers.16 Developed 
and validated by Brown (2014),17 it consists 
of general statements about wearing the 
compression stocking (five items) and of 
affirmations about the daily self- care tasks 
(16 items), that the persons can agree or not 
with a scale from 0 (total disagreement) to 
10 (total agreement). Mean scores for each 
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item can be compared. Its internal reliability is 0.931.17 
There is no comparable tool in French that measures self- 
efficacy in persons with venous ulcers. In agreement with 
the original author, a translation and psychometric explo-
ration of the VeLUSET were undertaken in a clinical 
context, within the French- speaking part of Switzerland.
PurPOSe Of the StuDy
To evaluate the psychometric properties and in partic-
ular the internal consistency and reliability of the Swiss- 
French version of the Venous Leg Ulcer Self Efficacy Tool 
(VeLUSET).
DeSIgn
After the forward and backward translation as described 
by Maneesriwongul and Dixon,18 a separate study was 
conducted to determine the internal consistency and reli-
ability of the VeLUSET- FR for use in the VLU- population 
in the French- Speaking part of Switzerland using a test–
retest design.
Sample size
Calculation of the required sample size for the study 
was conducted using Power Analysis Sample Size (PASS) 
software.19 Significance level (alpha) was set at 0.05 (two- 
tailed), items at 30, power at 0.9, the expected effect size 
at 0.3 (conservative estimate). The required sample size 
was 27 participants.
Setting and public patient involvement
A sample of 32 consecutive persons with VLU from three 
wound care centres in the French speaking part of Swit-
zerland was recruited (centre A: 18; centre B: 13; centre 
C: 1). All participants met the following inclusion criteria: 
having a healed or recurrent ulcer, suitable for compres-
sion therapy, an ankle brachial systolic pressure index 
between 0.8 and 1.3, be over 18 years of age, a return 
visit scheduled within 2 weeks and proficiency in French 
language. Trained staff nurses at the participating centres 
screened the daily appointment lists in order to iden-
tify potential participants. Subsequently those persons 
meeting the inclusion criteria were asked for consent 
to be referred to the study nurse for recruitment. The 
recruitment into the study and data collection period was 
from February to October 2018.
the instrument
The original version of the VeLUSET was developed to 
measure self- care and self- efficacy in English persons 60 
years of age and older with venous ulcers.16 The tool is 
a 30- item self- report that assesses the four dimensions of 
self- efficacy for persons with VLU: general self- care (five 
items), daily self- care tasks (12 items), normal living (four 
items), developing expertise (six items) and avoiding 
trauma (three items). The scale was developed by focus 
groups made up of people who are experiencing VLU. 
The items were written in the form of statements based 
on self- efficacy findings. This formulation assesses the 
person's understanding of the aetiology of their ulcer 
and provides the latest recommendations on self- care 
to be adopted. The scale is presented in a Likert format 
between 0 (totally disagree) and 10 (totally agree). The 
content validity of the tool was confirmed by a panel of 
four experts. The VeLUSET has been reported to have 
good internal consistency for the total scale (Cron-
bach alpha=0.931) and for the subscales (Cronbach 
alpha=0.834; 0.851; 0.753; 0.828 and 0.804 respectively). 
The test–retest reliability over a 4- week interval shows 
a strong positive Pearson's correlation (r=0.92; n=20; 
p<0.001).
Demographic background
The demographic section of the questionnaire included 
questions about participants’ age, gender, highest level of 
education and number of recurrences.
DAtA COlleCtIOn PrOCeDure
Administration of the Swiss-french version of the VeluSet
Internal consistency and reliability of the translated 
VeLUSET- scale was assessed in a test–retest study of 32 
respondent’s after a period of 14 days. A timeframe of 
2 weeks between initial and repeat data collection is 
suggested by Sharma19 to minimise the influence of clin-
ical changes.
DAtA AnAlySIS
SPSS V.2520 was used for data entry and analysis. Data 
entry was conducted by MT and audited by SP for accu-
racy. Summary descriptive statistics of the demographic 
characteristics of the study population were calculated. 
Cronbach alpha was calculated to assess the internal 
consistency of both the test and retest results of the Swiss- 
French version of the VeLUSET. Further assessment of 
reliability was conducted using Spearman’s correlation 
coefficient between subscales and all items. As the data 
was non- parametric a paired Wilcoxon test was used to 
assess the differences between test and retest results.
A Bland and Altman plot of differences against averages 
of test and retest results was created. Pearson’s correla-
tion coefficient was calculated to assess the relationship 
between differences and averages.21 22 Further the Lin 
concordance correlation coefficient between test and 
retest results as well as the 95% CI was calculated.23
ethical approval
All participants received an information document and 
a consent form detailing the objectives of the study, the 
procedures involved, insurance and confidentiality of the 
data. All participants gave their written consent prior to 
data collection.
reSultS
Participation rate
Of the 35 potential participants invited, 32 provided 
informed consent resulting in a participation rate of 91%. 
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Table 1 Demographic characteristics of study population 
n=32
Characteristic*
Mean age (SD) 70.8 (15.8)
Male 61.8 (17.0)
Female 75.5 (13.2)
Gender
Male 11 34.4
Female 21 65.6
Marital status
Single 5 15.6
Married 12 37.5
Divorced 3 9.4
Widowed 12 37.5
Highest education level
Primary school 8 25
Compulsory school 6 18.8
Vocational training 17 53.1
Tertiary education 1 3.1
Professional activity
In paid employment 6 18.8
Retired 24 75
Disability pension 2 6
* Values given are either mean and SD or absolute and relative 
frequencies.
Table 2 Spearman’s correlation coefficients between VeLUSET- FR subscales (test) and Cronbach alpha values based on 32 
answers.
Subscales of VeLUSET- FR Cronbach alpha
General self- 
care
Daily self- care 
tasks
Normal 
living
Developing 
expertise
Avoiding 
trauma Test Retest
General self- care – 0.883 0.907
Daily self- care tasks 0.760* – 0.900 0.860
Normal living 0.603* 0.658* – 0.979 0.956
Developing expertise 0.709* 0.755* 0.638* – 0.895 0.867
Avoiding trauma 0.621* 0.717* 0.612* 0.671* – 0.740 0.855
Total 0.964 0.957
* Significant at 0.01 level, two- sided.
All participants completed the questionnaires at the time 
of testing and retesting with no missing data.
Demographic characteristics of study population
Of the 32 participants the majority (65.6%, n=21) was 
female, retired (75%, n=24), had an education level of 
vocational training (53.1%, n=17) and was either married 
or widowed (37.5% each, n=12) (table 1). The mean age 
of all participants was 70.8 years (SD 15.8), ranging from 
41 years to 96 years. The mean age of male participants 
with 61.8 years (SD 17.0; 95% CI 50.4 to 73.2) was younger 
than that of female participants with 75.5 years (SD 13.2; 
95% CI 69.5 to 81.5).
time between measurements
The mean time between the administration of test and 
retest was 16.4 days (SD 4.11), with a minimum of 10 
and a maximum of 27 days. The majority of participants 
(80%) were retested after 12 to 21 days.
Internal consistency
Cronbach alpha for the five subscales ranged between 
0.74 and 0.98 on the first measurement and 0.86 and 0.96 
on the second measurement while that of the total score 
was 0.96 (95% CI 0.93 to 0.98 on both occasions (table 2). 
The lowest subscale scores for Cronbach alpha were for 
‘avoiding trauma’ with values of 0.74 and 0.86 at test and 
retest whereas the two highest subscale scores were for 
‘normal living’ with 0.98 and 0.96 respectively. Spear-
man’s correlation coefficients between the subscales were 
all significant (table 2).
reliability
The inspection of the scatterplot of the test versus the 
retest scores showed that the responses on the retest 
were on average lower (median 230.5; IQR (209.25; 
275.00); range 79–299) than on the initial test (median 
237.50; IQR (196.75; 265.00); range 71–300) (p=0.338, 
two- sided).
The agreement between the single items ranged from 
28.1% to 71.9%. The Bland- Altman plot of the averages 
of test and retest scores versus the differences of the test 
and retest scores shows concordance between test and 
retest scores (figure 1). The Limits of Agreement (−40.16; 
48.16) contain 30 of the 32 measurement pairs also indi-
cating good agreement.
Lin’s concordance correlation coefficient of the test 
and retest scores was 0.929 with a 95% CI from 0.86 to 
0.96 two- sided, Pearson’s correlation coefficient for this 
relationship was not significant (r=0.10; p=0.625) demon-
strating good overall reproducibility.  on
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Figure 1 Bland- Altman plot for 32 participants.
DISCuSSIOn
This study was conducted to determine the psychometric 
properties of the VeLUSET- FR. A response rate of 91% was 
achieved in this study. The questionnaire was easily under-
standable and was well accepted as demonstrated by the high 
participation rate and the high level of data- completeness 
(no missings). The mean age of participants in our study 
was 71 years compared with the one of the original study 
(74 years) which is comparable.17 The VeLUSET- FR also 
demonstrated an acceptable internal consistency with a 
total score of 0.96. Again this is a similar Cronbach alpha 
value like the one reported by Brown et al which was 0.93.
This study’s findings on reliability demonstrate that the 
responses on the retest were on average lower (median 
230.5; IQR (209.25; 275.00); range 79–299) than on the 
initial test (median 237.50; IQR (196.75; 265.00); range 
71–300) (p=0.338, two- sided) which is expected and 
compares to the validation study conducted by Brown.
In addition to Brown’s validation study on the VeLUSET 
instrument we expanded the examination of the psycho-
metric properties by producing a Bland- Altman plot as 
well as Lin’s concordance between test and retest as a 
demonstration of the reliability of the instrument. The 
results indicate an overall good reproducibility of 0.929 
with a 95% CI from 0.86 to 0.96 two- sided although the 
Pearson’s correlation coefficient for this relationship was 
not significant (r=0.10; p=0.625).
A possible limitation of the study is a restriction of the 
generalisation of the findings to the French speaking popu-
lation in Switzerland as well as a relatively small sample size.
COnCluSIOn
The psychometric properties of the Swiss French version 
of the VeLUSET are based on good quality data. Validity 
and reliability are adequate and comparable to the psycho-
metric properties of the original instrument. Therefore we 
recommended the VeLUSET- FR for the measurement of 
self- care in the Swiss French venous leg ulcer population.
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